JP2022522890A5 - - Google Patents

Info

Publication number
JP2022522890A5
JP2022522890A5 JP2021552591A JP2021552591A JP2022522890A5 JP 2022522890 A5 JP2022522890 A5 JP 2022522890A5 JP 2021552591 A JP2021552591 A JP 2021552591A JP 2021552591 A JP2021552591 A JP 2021552591A JP 2022522890 A5 JP2022522890 A5 JP 2022522890A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
tautomers
stereoisomers
acceptable salts
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021552591A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022522890A (ja
JP7470708B2 (ja
Filing date
Publication date
Priority claimed from PCT/CN2019/076926 external-priority patent/WO2020177067A1/en
Application filed filed Critical
Publication of JP2022522890A publication Critical patent/JP2022522890A/ja
Publication of JP2022522890A5 publication Critical patent/JP2022522890A5/ja
Application granted granted Critical
Publication of JP7470708B2 publication Critical patent/JP7470708B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021552591A 2019-03-05 2020-02-19 芳香族誘導体、その調製方法および医薬用途 Active JP7470708B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2019/076926 2019-03-05
PCT/CN2019/076926 WO2020177067A1 (en) 2019-03-05 2019-03-05 Aromatic derivatives, preparation methods, and medical uses thereof
PCT/CN2020/075849 WO2020177534A1 (en) 2019-03-05 2020-02-19 Aromatic derivatives, preparation methods, and medical uses thereof

Publications (3)

Publication Number Publication Date
JP2022522890A JP2022522890A (ja) 2022-04-20
JP2022522890A5 true JP2022522890A5 (cg-RX-API-DMAC7.html) 2023-02-28
JP7470708B2 JP7470708B2 (ja) 2024-04-18

Family

ID=72337401

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021552591A Active JP7470708B2 (ja) 2019-03-05 2020-02-19 芳香族誘導体、その調製方法および医薬用途

Country Status (10)

Country Link
US (1) US11976058B2 (cg-RX-API-DMAC7.html)
EP (1) EP3935048A4 (cg-RX-API-DMAC7.html)
JP (1) JP7470708B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210135558A (cg-RX-API-DMAC7.html)
CN (1) CN111902400B (cg-RX-API-DMAC7.html)
CA (1) CA3132405A1 (cg-RX-API-DMAC7.html)
PH (1) PH12021552133A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202109522VA (cg-RX-API-DMAC7.html)
TW (1) TWI860334B (cg-RX-API-DMAC7.html)
WO (2) WO2020177067A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12595370B2 (en) 2018-03-02 2026-04-07 Johnson & Johnson Vision Care, Inc. Polymerizable absorbers of UV and high energy visible light
US10935695B2 (en) 2018-03-02 2021-03-02 Johnson & Johnson Vision Care, Inc. Polymerizable absorbers of UV and high energy visible light
US12595371B2 (en) 2018-03-02 2026-04-07 Johnson & Johnson Vision Care, Inc. Contact lens with improved vision break-up time
US12674032B2 (en) 2019-06-28 2026-07-07 Johnson & Johnson Vision Care, Inc. Polymerizable fused tricyclic compounds as absorbers of UV and visible light
US20220194944A1 (en) * 2020-12-18 2022-06-23 Johnson & Johnson Vision Care, Inc. Photostable mimics of macular pigment

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012271357A1 (en) 2011-06-16 2013-05-02 Ionis Pharmaceuticals, Inc. Antisense modulation of fibroblast growth factor receptor 4 expression
NZ703495A (en) * 2012-07-11 2018-02-23 Blueprint Medicines Corp Inhibitors of the fibroblast growth factor receptor
JP6084292B2 (ja) 2013-07-18 2017-02-22 大鵬薬品工業株式会社 Fgfr阻害剤耐性癌の治療薬
SG11201602069WA (en) 2013-10-18 2016-04-28 Eisai R&D Man Co Ltd Pyrimidine fgfr4 inhibitors
PT3395814T (pt) 2013-10-25 2022-07-27 Blueprint Medicines Corp Inibidores do recetor do fator de crescimento de fibroblastos
CN105683188B (zh) 2013-10-25 2018-02-09 诺华股份有限公司 作为fgfr4抑制剂的稠环二环吡啶基衍生物
WO2015108992A1 (en) * 2014-01-15 2015-07-23 Blueprint Medicines Corporation Heterobicyclic compounds and their use as fgfr4 receptor inhibitors
MA38393B1 (fr) 2014-03-13 2018-11-30 Sanofi Sa Composés hétéroaryle et utilisations associées
JP6655559B2 (ja) 2014-06-24 2020-02-26 コベストロ、ドイチュラント、アクチエンゲゼルシャフトCovestro Deutschland Ag ジフェニルメタン系ジアミンおよびポリアミンの製造方法
WO2016064960A1 (en) * 2014-10-22 2016-04-28 Incyte Corporation Bicyclic heterocycles as fgfr4 inhibitors
EP3029864B1 (en) 2014-12-01 2020-11-18 Harman Becker Automotive Systems GmbH Fast representation of station information in a fm receiver using a single tuner
CA2976790C (en) 2015-02-20 2024-02-27 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
US9580423B2 (en) * 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
CN105906630B (zh) 2015-04-06 2018-10-23 四川百利药业有限责任公司 用作fgfr抑制剂的n-(1h-吡唑-5-基)嘧啶并吡唑-4,6-二取代胺类化合物
WO2016164703A1 (en) 2015-04-09 2016-10-13 Eisai R & D Management Co., Ltd. Fgfr4 inhibitors
CN107286130A (zh) * 2016-04-13 2017-10-24 成都融科博海科技有限公司 一种激酶选择性抑制剂
RU2747260C2 (ru) * 2016-12-19 2021-04-29 Аббиско Тхерапеутицс Цо., Лтд. Ингибитор рфрф4, способ его получения и его фармацевтическое применение
CN110997637B (zh) * 2017-09-05 2022-09-27 保仕健生物科技(上海)有限公司 芳香类衍生物、其制备方法及其在医药上的应用
CN109224235B (zh) 2018-10-23 2020-05-19 孙喜家 一种双腔管
CN109331654A (zh) 2018-10-26 2019-02-15 高邮高和光电器材有限公司 一种有机废气光催化氧化装置

Similar Documents

Publication Publication Date Title
JP6907173B2 (ja) スルファモイル−アリールアミド及びb型肝炎の治療のための薬剤としてのその使用
JP2021534124A5 (cg-RX-API-DMAC7.html)
JP2023515617A5 (cg-RX-API-DMAC7.html)
JP2023520925A5 (cg-RX-API-DMAC7.html)
JP2007502264A5 (cg-RX-API-DMAC7.html)
JP2023515620A5 (cg-RX-API-DMAC7.html)
JP2020507589A5 (cg-RX-API-DMAC7.html)
JP2023520924A5 (cg-RX-API-DMAC7.html)
JP2021532124A5 (cg-RX-API-DMAC7.html)
JP2023515621A5 (cg-RX-API-DMAC7.html)
JP2012530703A5 (cg-RX-API-DMAC7.html)
JP2023541522A5 (cg-RX-API-DMAC7.html)
JP2025071130A5 (cg-RX-API-DMAC7.html)
JP2004525179A5 (cg-RX-API-DMAC7.html)
JP2008509187A5 (cg-RX-API-DMAC7.html)
RU2003105885A (ru) Ингибиторы клеточной адгезии, опосредованной альфа 4-интегринами
JP2006509749A5 (cg-RX-API-DMAC7.html)
JP2012236838A5 (cg-RX-API-DMAC7.html)
JP2024513227A5 (cg-RX-API-DMAC7.html)
JP2022501429A5 (cg-RX-API-DMAC7.html)
BR112015029463B1 (pt) Bissulfato de inibidor da janus quinase (jak), seu uso e seu método de preparação, e composição farmacêutica
JP2013542267A5 (cg-RX-API-DMAC7.html)
JP2019533642A5 (cg-RX-API-DMAC7.html)
JP2019530674A5 (cg-RX-API-DMAC7.html)
RU2006101541A (ru) Производные пиперазина и способ их применения